Possible venlafaxine withdrawal syndrome.
Farah
A
A
Lauer
T E
TE
D000328:Adult; D003511:Cyclohexanols / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy*; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D014012:Tinnitus / Q000139:chemically induced; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride